Celecoxib Combined with Diacerein Effectively Alleviates Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling Pathways.
about
Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.Silencing of Wnt5a prevents interleukin-1β-induced collagen type II degradation in rat chondrocytes.JNK pathway in osteoarthritis: pathological and therapeutic aspects.Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells.Anti-Inflammatory Effect of Geniposide on Osteoarthritis by Suppressing the Activation of p38 MAPK Signaling Pathway.Up-regulated expression of E2F2 is necessary for p16INK4a-induced cartilage injury
P2860
Q36316432-0445F819-1E9D-40D4-B197-2FEB4F9A19DFQ37406511-FBC3D476-AC61-4013-9661-0A07DDFEC28CQ38641796-5B7D7627-D4A9-4498-874F-72BC7CFE05B8Q41282592-BD9D4904-0658-4A08-AFA9-0EE1E5621491Q41406149-426E2237-C8F4-4010-BDBF-79F011F84EC6Q52571019-98627E7D-D2FE-4582-8AE9-F3684041497BQ58737840-1EC7488A-604D-4B49-89D9-E95BE865AF2D
P2860
Celecoxib Combined with Diacerein Effectively Alleviates Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling Pathways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@en
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@nl
type
label
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@en
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@nl
prefLabel
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@en
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@nl
P2093
P2860
P1433
P1476
Celecoxib Combined with Diacer ...... nd p38MAPK Signaling Pathways.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10753-015-0131-3
P50
P577
2015-08-01T00:00:00Z
P6179
1010554643